Search Results 821-830 of 9590 for Sulfasalazine

  1. A Study To Evaluate The Effectiveness And Safety Of Ibrexafungerp In Patients With Fungal Diseases That Are Refractory To Or Intolerant Of Standard Antifungal Treatment - Mayo Clinic

    The purpose of this study is to see how well study drug works at treating people with fungal diseases that are refractory to or intolerant of Standard ...

  2. A Study to Evaluate Food on Gastrointestinal Toxicity and The Effect of Selumetinib in Adolescents with Neurofibromatosis Type 1 - Mayo Clinic

    About this study. The purpose of this study in adolescent participants is to evaluate the effect of a low fat meal on steady state selumetinib exposure; ...

  3. Phase 2 Study To Evaluate The Oral Combination Of Ixazomib (MLN9708) With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Or Relapsed And/or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

  4. General Internal Medicine - Clinical trials

    Rochester, Minn. This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption ...

  5. Vasculitis - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  6. Soft Tissue Sarcoma Clinical Trials - Mayo Clinic Research

    This allows immune cells to recognize and attack tumor cells. The drug could shrink cancer but could also have side effects. Researchers want to study if the ...

  7. Fluorescein (intravenous route) - Side effects & uses - Mayo Clinic

    Fluorescein injection is used to help certain parts of the eye (eg, retina, iris) become more visible during eye medical procedures. This medicine is to be ...

  8. Clinical trials - Gastroenterology and Hepatology

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  9. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    About this study. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other ...

  10. Pazopanib As Front-Line Therapy In Patients With Non-Resectable Or Metastatic Soft Tissue Sarcomas Who Are Not Candidates For Chemotherapy - Mayo Clinic

    About this study. Pazopanib is FDA approved as a second line and beyond treatment for metastatic soft tissue sarcoma. There is a population of elderly and ...